Clinical Trial Update: Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated pegfilgrastim as supportive therapy for neutropenia in patients with advanced breast cancer undergoing chemotherapy; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Amgen | Conditions: Neutropenia | Phase 3 | Status: COMPLETED